Broker analysis

To my surprise Morninstar has started coverage of AVH. Their fair price estimate is 95cps.
They think AVH will gain 50% market share in 5 years and estimate revenue to he around 640m aud in 2029.

I take analyst estimates with a grain of salt but find the reasoning behind their SP valuation useful.
Are there any other analysts covering the stock? More than the SP valuation I am interested in revenue forecasts. Mornigstar estimates Avita will reach 20% market share by the end of this year. Please share these if you have any.

in my opinion Morningstar analysis is bullish and if it did indeed play out, there is significant upside potential to the SP. I still remember when they were pumping Mayne Pharma for $2 when the SP was well below 1 dollar. However key difference here is that mayne Pharma was in generics and the generics price went down and squeezed margins. With some of these brokers I almost feel more comfortable when their target price is well below today's SP. .. it's hard to believe they think there is 30% odd upside to the current share price and they want to share that information with us so we can make money.